Oculus Innovative Sciences Receives European CE Mark for New MucoClyns for First Responders

Oculus Innovative Sciences, Inc. OCLS today announced the issuance of a new CE Mark in Europe for Microcyn-based MucoClyns™, a Microcyn-based solution intended for use in emergencies. It is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces for treatment immediately after an unexpected exposure to infection risk, and before receiving professional medical attention. "Oculus has a strong commitment to helping military personnel, fire department, police officers and all of the brave men and women called into action as first responders to safely handle unexpected infection risks, both to their patients and themselves in emergency settings," said Lori Smith, senior vice president of marketing and sales for Oculus.  "MucoClyns  is an easy-to-use one-step solution that helps to prevent infection and provide first responders with a clinically proven formulation that can be used in all situations since it is as safe as saline and non-flammable." Oculus is currently in discussions with potential European partners for the distribution of MucoClyns in Europe.  Future consumer applications See full press release